Literature DB >> 10448402

The management of difficult anogenital warts.

A McMillan1.   

Abstract

Mesh：

Year:  1999        PMID： 10448402      PMCID： PMC1758215          DOI： 10.1136/sti.75.3.192

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN： 1368-4973            Impact factor:   3.519


× No keyword cloud information.
  4 in total

1.  Recombinant human interferon-beta in the treatment of condylomata acuminata.

Authors:  W Dinsmore; J Jordan; C O'Mahony; J R Harris; A McMillan; K W Radcliffe; P Engrand; B W Jackson; A R Galazka; A K Abdul-Ahad; J M Illingworth
Journal:  Int J STD AIDS       Date:  1997-10       Impact factor: 1.359

2.  Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial.

Authors:  G Gross; A Roussaki; S Baur; M Wiegand; A Mescheder
Journal:  Genitourin Med       Date:  1996-02

3.  Treatment of genital warts with an immune-response modifier (imiquimod).

Authors:  K R Beutner; S L Spruance; A J Hougham; T L Fox; M L Owens; J M Douglas
Journal:  J Am Acad Dermatol       Date:  1998-02       Impact factor: 11.527

4.  Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions.

Authors:  I Arany; S K Tyring
Journal:  J Interferon Cytokine Res       Date:  1996-06       Impact factor: 2.607
  4 in total
  2 in total

1.  Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.

Authors:  Lieven Annemans; Vanessa Rémy; James Oyee; Nathalie Largeron
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  [HPV vaccination is important for dermatologists].

Authors:  G Gross
Journal:  Hautarzt       Date:  2008-11       Impact factor: 0.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.